Radioprotective properties of sodium humate in radiation-induced mutagenesis in cultured lymphocytes of thyroid cancer patients by Shkarupa, V.M. & Klymenko, S.V.
108 Experimental Oncology 38, 108–111, 2016 (June)
RADIOPROTECTIVE PROPERTIES OF SODIUM HUMATE 
IN RADIATION-INDUCED MUTAGENESIS IN CULTURED 
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Aim: To investigate the effect of sodium humate on the level of cytogenetic damage in culture of lymphocytes of patients with thyroid 
cancer after γ-irradiation. Materials and Methods: Metaphase analysis of chromosome aberrations in cultured peripheral blood 
lymphocytes of 10 individuals with thyroid cancer was performed after irradiation of lymphocytes in vitro at a dose of 1 Gy from 137Cs 
source at the early G0 phase of cell cycle. Sodium humate was added to cell culture for 30 ± 15 min after phytohemagglutinin stimula-
tion at concentrations of 10 and 100 μg/ml. Results: Sodium humate exhibited antimutagenic properties. The preparation at a con-
centration of 10 μg/ml was more effective than at a concentration of 100 μg/ml, reducing the average incidence of radiation-induced 
chromosome aberrations by 51.88 and 38.77%, respectively. The most pronounced antimutagenic effect of sodium humate was the 
reduction of the frequency of chromosomal type aberrations, however, such efficiency varied between individual patients with thyroid 
cancer. Conclusions: Sodium humate could be considered as a potential therapeutic modifier of radiation damage.
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Currently, the scientific literature presents numer-
ous data on biological activity of humic substances. 
Their preparations are being used both in medicine 
and agriculture [1–4]. Humic substances are a com-
plex of natural polymer compounds, products of hu-
mification, which are present in the soil, peat, brown 
coal, sapropel, etc. The main component of the humic 
substances is humic acid, which physiologically active 
form is salts (humates). The feature of humic sub-
stances is the saturation of their molecules by most 
diverse functional groups, namely carboxyl, phenolic 
and alcoholic hydroxyls, quinoid groups, methoxy, ami-
no and amido groups [1] that ultimately provides the 
widest range of their biological activity [2–4]. Particular 
attention is drawn to antitumor properties of humic 
substances. Their antiangiogenic and proapoptotic 
properties are found as well [5–7]. Antitumor activity 
of humic substances was showed in various models 
of transplantable tumors, spontaneous and induced 
tumors, in human tumor cell lines [8]. Moreover, hu-
mic substances are characterized as non-toxic [4]. 
Noteworthy that preparations of humic substances 
with antitumor activity do not have long-term adverse 
effects [9].
In the last decade intense studies of humic sub-
stances have shown the potential of a significant 
extending of their pharmacological application. The 
scientific literature describes their antioxidant, im-
munostimulatory, anti-inflammatory and antiviral 
effects [1–4, 10–12]. It was shown that humic sub-
stances may change the expression profile of more 
than 30 genes, and affect DNA methylation [13, 14]. 
Considering adaptogenic and immune-stimulating 
properties of humic substances, their ability to in-
crease non-specific resistance of a human body could 
be assumed [1–4, 10–12]. There is an increasing in-
terest in the study of their use in cancer radiotherapy 
to protect normal tissues, to improve the tolerability 
of the treatment, and to reduce the risk of early and late 
side effects. One of these effects of radiotherapy is its 
significant mutagenic effect on non-transformed cells, 
in particular of hematopoietic system, which increases 
the risk of secondary cancer. It should be noted, that 
most of studies testing this hypothesis were performed 
in culture of lymphocytes of healthy individuals. There 
are few publications describing studies of spontane-
ous and induced mutagenesis in diseased persons, 
especially in cancer patients [15, 16].
Thyroid cancer is one of the most severe con-
sequences of the Chornobyl accident. Increased 
quantity of TCR-mutant cells in patients with thyroid 
cancer was revealed that may be due to genotoxic 
effects, increased by genetic instability (especially 
radiation-induced) [17]. In patients with thyroid cancer 
living in areas contaminated with radionuclides, there 
was found an increased level of cytogenetic damage 
in cultured peripheral blood lymphocytes [15]. This 
makes reasonable the attempts to modify radiation-
induced mutagenesis in somatic cells of patients with 
thyroid cancer.
The aim of this work was to investigate the effect 
of sodium humate on the level of cytogenetic damage 
in cultured lymphocytes of patients with thyroid cancer 
after γ-irradiation.
MATERIALS AND METHODS
Metaphase analysis of chromosomal aberrations 
in peripheral blood lymphocyte cultures was carried 
out in 10 thyroid cancer patients. The patients were 
treated in National Research Center for Radiation 
Medicine of National Academy of Medical Sciences 
of Ukraine. The study has been performed in accor-
dance with ethics rules for biomedical research. All 
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patients gave an informed consent for the participa-
tion in the study.
Irradiation of lymphocytes was held in vitro 
at a dose of 1 Gy from 137Cs source (IBL 437C, France, 
dose rate — 2.46 Gy/min) in the early G0 phase of the 
cell cycle. After phytohemagglutinin stimulation, dur-
ing 30 ± 15 min after radiation exposure, sodium hu-
mate (Agrohіmpak, Ukraine) was added to the culture 
of lymphocytes at concentrations of 10 or 100 μg/ml. 
In each case, at least 100 metaphases were examined 
for numerical as well as structural aberrations. The 
ave rage group indexes were calculated as the ratio 
of the total number of chromosomal aberrations to the 
total number of analyzed cells. Antimutagenic acti-
vity was determined by a reduction in the frequency 
of chromosome aberrations that was calculated 
as a percentage. Probability of differences was as-
sessed by the criterion of Fisher.
RESULTS AND DISCUSSION
Table 1 shows the results of analysis of the sodium 
humate impact on the frequency of spontaneous and 
radiation-induced chromosome aberrations in lympho-
cyte cultures of thyroid cancer patients.
Table 1. Antimutagenic effect of sodium humate in the culture of periphe-
ral blood lymphocytes of patients with thyroid cancer after irradiation in vi-
tro at a dose of 1 Gy from 137Cs
Treatment
Frequency 
of chromosome 
aberrations per 
100 cells
Anti-
muta-
genic ef-
fect, %
Control 3.75 ± 0.51 –
Sodium humate, 10 μg/ml 2.61 ± 0.46* –
Sodium humate, 100 μg/ml 3.65 ± 0.52 –
Irradiation, 1 Gy 21.51 ± 0.95 –
Irradiation, 1 Gy + sodium humate, 10 μg/ml 10.35 ± 0.66** 51.88***
Irradiation, 1 Gy + sodium humate, 100 μg/ml 13.17 ± 0.69** 38.77
Note: *р = 0.08 compared to untreated control; **p < 0.05 compared to the 
effect of irradiation; ***р < 0.05 compared to irradiation, 1 Gy with addition 
of sodium humate, 100 μg/ml.
The average spontaneous frequency of chro-
mosome aberrations was 3.75 ± 0.51 aberrations 
per 100 cells. However, a range of minimal and 
maximal individual values of this index varied from 
0.00 to 8.15 ± 2.36 aberrations per 100 cells. Sodium 
humate at a concentration of 100 μg/ml did not reduce 
the mean values of spontaneous mutagenesis. The 
tendency to reduce the average frequency of sponta-
neous aberrations in cultured lymphocytes of thyroid 
cancer patients (2.61 ± 0.46 aberrations/100 cells) 
modified by humic preparation at a concentration 
of 10 μg/ml had insufficient level of statistical signifi-
cance (p = 0.08). The average frequency of chromo-
some aberrations in cultured lymphocytes of patients 
with thyroid cancer after irradiation in vitro was 21.51 ± 
0.95 aberrations/100 cells. The range of minimal and 
maximal individual values of this index varied from 
13.16 ± 2.49 to 27.50 ± 4.08 aberrations per 100 cells. 
Addition of sodium humate after exposure has shown 
an expressed antimutagenic effect. Antimutagenic 
efficiency of sodium humate at a concentration 
of 10 μg/ml (antimutagenic effect — 51.88%) was 
significantly higher (p < 0.05) than by the impact of the 
preparation at a concentration of 100 μg/ml (antimu-
tagenic effect — 38.77%).
Reduction of the radiation-induced chromosome 
aberrations frequency as a result of the sodium humate 
action was mainly due to the decrease of aberrations 
of chromosomal type (Table 2). Reduction of the 
average frequency of aberrations of chromatide type 
to 26.44% by addition of the preparation at a concen-
tration of 10 μg/ml, and to 24.92% by addition of the 
preparation at a concentration of 100 μg/ml had not 
reached statistical significance.
Table 2. Effect of sodium humate on the frequency of radiation-induced 
chromosomal and chromatide type aberrations (average value)
Treatment
Frequen-
cy of chroma-
tide type aber-
rations per 
100 cells
Anti-
muta-
genic 
effect, 
%
Frequen-
cy of chromo-
somal type 
aber rations 
per 100 cells
Anti-
muta-
genic 
effect, 
%
Irradiation, 1 Gy 3.29 ± 0.41 – 18.22 ± 0.90 –
Irradiation, 1 Gy + sodi-
um humate, 10 μg/ml
2.42 ± 0.33 26.44 7.92 ± 0.58* 56.53*
Irradiation, 1 Gy + sodi-
um humate, 100 μg/ml
2.47 ± 0.32 24.92 10.70 ± 0.63* 41.27*
Note: *p < 0.05 as compared to the effect of irradiation.
Analysis of cytogenetic indexes at the individual 
level (Table 3 and 4) found significant differences in the 
response on radiation exposure and antimutagenic 
effect of sodium humate.
Table 3. Individual indexes of antimutagenic effect of sodium humate 
(10 μg/ml) in the culture of peripheral blood lymphocytes of patients with 
thyroid cancer after irradiation in vitro at a dose of 1 Gy from 137Cs
Culture 
of lym-
phocytes,
pa-
tient’s ID
Frequency of chromosome aberrations per 100 cells Anti-
muta-
genic 
effect, 
%
Control
Sodium hu-
mate
(10 μg/ml)
Irradiation,
1 Gy
Irradiation, 
1 Gy + sodium 
humate
(10 μg/ml)
Т1 0.00 ± 0.00 1.00 ± 0.99 18.00 ± 2.72 9.55 ± 1.98** 46.94
Т2 0.39 ± 0.38 0.83 ± 0.83 13.16 ± 2.49 4.76 ± 1.47** 63.83
Т3 0.73 ± 0.72 0.95 ± 0.95 16.33 ± 2.13 6.67 ± 1.44** 59.16
Т4 1.00 ± 0.99 2.00 ± 1.40 22.50 ± 3.30 16.67 ± 2.54*** 25.91
Т5 2.99 ± 1.47 2.00 ± 1.40 19.00 ± 2.77 8.00 ± 1.92** 57.90
Т6 3.85 ± 1.69 2.00 ± 1.40 16.00 ± 2.99 6.00 ± 1.37** 62.50
Т7 4.88 ± 1.51 3.00 ± 1.71 19.00 ± 3.92 16.00 ± 3.67*** 15.79
Т8 5.80 ± 1.56 5.00 ± 1.62 15.00 ± 3.57 14.00 ± 2.45*** 6.67
Т9 6.60 ± 1.46 2.73 ± 1.09* 27.25 ± 2.09 10.00 ± 2.12** 63.30
Т10 8.15 ± 2.36 6.00 ± 2.38 27.50 ± 4.08 18.50 ± 2.75** 32.73
Note: *р < 0.05 compared to untreated control; **p < 0.05 compared to the 
effect of irradiation; ***р > 0.05 compared to the effect of irradiation.
Table 4. Individual indexes of antimutagenic effects of sodium humate 
(100 μg/ml) in the culture of peripheral blood lymphocytes of patients with 
thyroid cancer after irradiation in vitro at a dose of 1 Gy 137Cs
Culture 
of lym-
phocytes, 
pati-
ent’s ID
Frequency of chromosome aberrations per 100 cells Anti-
muta-
genic 
effect, 
%
Control
Sodium 
humate 
(100 μg/ml)
Irradiation, 
1 Gy
Irradiation, 
1 Gy + sodi-
um humate 
(100 μg/ml)
Т1 0.00 ± 0.00 1.00 ± 0.99 18.00 ± 2.72 10.00 ± 2.02** 44.44
Т2 0.39 ± 0.38 0.87 ± 0.87 13.16 ± 2.49 5.58 ± 1.64** 57.60
Т3 0.73 ± 0.72 1.82 ± 1.28 16.33 ± 2.13 10.00 ± 2.37** 38.76
Т4 1.00 ± 0.99 3.33 ± 1.79 22.50 ± 3.30 15.83 ± 3.33*** 29.64
Т5 2.99 ± 1.47 4.00 ± 1.96 19.00 ± 2.77 9.50 ± 2.07** 50.00
Т6 3.85 ± 1.69 4.17 ± 1.82 16.00 ± 2.99 6.00 ± 1.37** 62.50
Т7 4.88 ± 1.51 4.00 ± 1.96 19.00 ± 3.92 15.83 ± 3.33*** 16.68
Т8 5.80 ± 1.56 6.79 ± 1.98 15.00 ± 3.57 17.60 ± 1.46*** −17.33
Т9 6.60 ± 1.46 3.79 ± 1.18* 27.25 ± 2.09 16.89 ± 2.50** 38.02
Т10 8.15 ± 2.36 7.00 ± 2.55 27.50 ± 4.08 18.45 ± 2.70 32.91
Note:*р < 0.05 compared to untreated control; **p < 0.05 compared to the 
effect of irradiation; ***р > 0.05 compared to the effect of irradiation.
Most researchers believe that if the preparation 
reduces the induced damage by less than 10%, 
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it could not be considered antimutagenic. Substances 
that reduce the frequency of aberrations at the range 
of 10.1–20.0% usually are being called “very weak”, 
and at in the range of 20.1–40.0% — “weak” anti-
mutagens. Reducing the frequency of aberrations 
by 40.1–80.0% is typical for the majority of antimu-
tagens of “average” performance. Substances, that 
can reduce the level of induced damage by more 
than 80%, are related to the group of “strong” anti-
mutagens [18]. In cultures of lymphocytes of patients 
T7 and T8 sodium humate did not show antimutagenic 
properties. In a lymphocyte culture of patient T4 weak 
antimutagenic activity of humic preparation (25.91% 
at a concentration of 10 μg/ml and 29.64% at a con-
centration of 100 μg/ml) had insufficient statistical 
significance. In other cases, sodium humate has 
showed the properties of antimutagen of “average 
efficiency”. Antimutagenic effect of sodium humate 
did not depend on the level of spontaneous or initial 
radiation-induced mutagenesis.
In the context of possible modifying of the spon-
taneous and induced mutagenesis in the culture 
of human lymphocytes the study on radioprotective 
properties of timalin should be mentioned [15, 16]. 
In the culture of lymphocytes of thyroid cancer pa-
tients, who reside in the territories of Ukraine with 
increased density of radioactive contamination from 
the Chornobyl accident, timalin reduced the average 
level of spontaneous chromosome aberrations from 
6.0 ± 0.7 to 2.0 ± 0.5% [15]. In our study, the aver-
age frequency of chromosome aberrations induced 
by sodium humate at a concentration of 10 μg/ml was 
similar and amounted to 2.61 ± 0.46 aberrations 
per 100 cells, although the spontaneous frequency 
was lower and amounted to 3.75 ± 0.51 aberrations 
per 100 cells. It is possible that studied substances 
can reduce the frequency of spontaneous chromo-
some aberrations only to a certain level, or under 
particular circumstances of increased spontaneous 
mutagenesis.
In a situation, where the individual frequency 
of spontaneous chromosome aberrations in the cul-
tured lymphocytes of thyroid cancer patients was with-
in the average population values (0–3 aberrations per 
100 cells), it showed no reduction of spontaneous level 
by addition of sodium humate. Among those with high 
levels of spontaneous mutagenesis, antimutagenic 
effect of sodium humate manifested in lymphocyte 
cultures of two patients (T9 and T10), in one of which 
(T9) preparation in both studied concentrations leads 
to the significant reduction of spontaneous frequency 
of chromosome aberrations.
Dyomina [15] have shown that the timalin added 
to cultured lymphocytes of thyroid cancer patients 
irradiated at a dose of 0.3 Gy, reduced the percent-
age of aberrant cells from 9.0 ± 1.7 to 2.1 ± 1.0%, 
compared to irradiated control. So, timalin could 
be effective if added before irradiation [19]. During 
timalin action on lymphocytes at G1 phase of cell 
cycle subsequently exposed to a high dose irradiation 
(2 Gy), the author observed an opposite cytogenetic 
effect, an increased frequency of radiation-induced 
aberrations from 18.0 ± 1.9 to 26.0 ± 2.5%, which was 
explained by timalin influence on radiation-induced 
mitotic delay [16]. The essential difference between 
these data and our study was that sodium humate 
showed antimutagenic effectiveness by its action after 
irradiation exposure. This allows considering it as a po-
tential therapeutic modifier of radiation damage [19].
It is believed that effectiveness of radioprotec-
tive substances after cell irradiation could be caused 
by activation of DNA repair or other irradiation reco-
very processes, in particular stimulation of repopula-
tion [19]. Repopulation as a reaction of organisms 
to irradiation exposure was studied in detail in many 
model systems, including its stimulation by antimu-
tagens [19–21]. Well-known adaptogenic proper-
ties of humates suppose their impact also on other 
processes of post-radiation recovery [1–4]. The view 
on mechanisms of radioprotective action of sodium hu-
mate in the culture of human lymphocytes is supported 
by the results of our previous studies done in plant 
test-system. In particular, the multiplicity of genopro-
tective mechanisms of humic substances, including 
the activating reparation processes and stimulation 
of repopulation has been shown [22].
In conclusion, antimutagenic effect of sodium 
humate was revealed, what allows to consider it as po-
tential therapeutic modifier of radiation damage. The 
preparation at a concentration of 10 μg/ml was more 
effective than at a concentration of 100 μg/ml, re-
ducing the average incidence of radiation-induced 
chromosome aberrations by 51.88 and 38.77%, 
respectively. Antimutagenic effect was manifested 
mainly by reduction of the frequency of chromosome 
type aberrations. There were individual differences 
in antimutagenic efficacy of sodium humate in cultured 
lymphocytes of thyroid cancer patients.
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